← SynDRA
OLOPATADINE
SynDRA canonical compound SYN0022866 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
- HRH1
- S100A1
- S100A12
- S100A13
- S100A2
- S100B
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD1
- DRD2
- GMNN
- HDAC6
- SAMHD1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Histamine H1 Receptor Antagonists
- Histamine-1 Receptor Inhibitor
- Histamine-1 Receptor Antagonist
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Allergic Agents
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- S01G · DECONGESTANTS AND ANTIALLERGICS
Cross-references
Synonyms
- OLOPATADINE HYDROCHLORIDE
- PATADAY ONCE DAILY RELIEF
- PATADAY TWICE DAILY RELIEF
- PATANASE
- Pataday
- RYALTRIS
- olopatadine hydrochloride
- opatanol
- pataday
- patanol
- olopatadine HCl
- Olopatadina
- AL-4943A
- Opatanol
- Allelock
- Patanase
- Patanol
- OLOPATADINE HCl
- ALO4943A
- HCl of KW 4679
- KW-4679
- O0361
- ALO-4943A
- Allelock (TN)
- KW-4943A
- Olopatadine [INN:BAN]
- Pataday (TN)
- Patanase (TN)
- Patanol S (TN)
- D27V6190PM
- Olopatadinum
- RefChem:56799
- DTXCID603390
- R01AC08
- S01GX09
- Olopatadine (INN)
- OLOPATADINE [INN]
- UNII-D27V6190PM
Reported adverse events
- Headache
- Epistaxis
- Somnolence
- Cough
- Depression
- Dry mouth
- Fatigue
- Influenza
- Nasal ulcer
- Nasopharyngitis
- Pyrexia
- Rash
Look up OLOPATADINE in the interactive SynDRA portal →